Occlutech

Switzerland - SchaffhausenMedical Devices

Focus: Occlutech is a Swiss-based medical device manufacturer specializing in minimally-invasive cardiac closure devices for structural heart defects and heart failure. Founded in 2003 and headquartered in Schaffhausen, the company operates in the cardiovascular device segment with a diversified portfolio spanning atrial septal defects, patent foramen ovale, patent ductus arteriosus, and emerging heart failure indications.

Cardiovascular

Profile data last refreshed 13h ago · AI intelligence enriched 3w ago

Open Jobs

About Occlutech

AI assessmentNot Hiring

No open roles listed right now. Follow Occlutech to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Mid-stage

2 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Closure of bronchopleural fistula with Occlutech Figulla

Bronchopleural Fistula

N/A

Clinical Trials (1)

NCT01153074Bronchoscopic Closure of Bronchopleural Fistulas With Occlutech Figulla ASD N Occluder Device

N/A

Help build intelligence for Occlutech

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Diversified pipeline across 20 clinical programs spanning multiple high-prevalence cardiac indications with significant market opportunities in structural heart disease.
Established device company with 20+ years of operational history (founded 2003) and commercial presence across cardiovascular markets, offering stability relative to early-stage medtech startups.
Active Phase 3 development in PFO closure for cryptogenic stroke—a multi-billion dollar indication with clear regulatory pathway and commercial potential.

Watch Out For

Zero active job openings currently listed, suggesting limited near-term hiring or potential organizational constraints; difficult to identify career momentum without visibility into headcount, revenue, or funding status.
Minimal transparency on financials, employee count, funding, or recent news—raises questions about company stability, growth trajectory, and internal visibility into future opportunities.
Pipeline dominated by follow-up registries and early-stage trials with only 2 Phase 3 programs; most indications remain in non-standardized trial phases, limiting near-term commercial catalysts and revenue visibility.

Generated by Claude from Occlutech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

A Multicenter, International, Prospective and Retrospective, Follow-up Registry to Monitor the Effic

Paravalvular Leak Device (PLD)

N/A

Clinical Trials (1)

NCT07037446A Multicenter, International, Prospective and Retrospective, Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech Paravalvular Leak Device (PLD) in Patients With Mitral or Aortic Paravalvular Leaks

N/A

A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® P

Perimembranous Ventricular Septal Defect

N/A

Clinical Trials (1)

NCT04034498A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects

N/A

Catheter implantation of Occlutech AFR device

Various

N/A

Clinical Trials (1)

NCT07421557Expanded Access of Occlutech's Atrial Flow Regulator

N/A

Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech PLD Device

Mitral Paravalvular Leaks (PVL)

N/A

Clinical Trials (1)

NCT03003481Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech PLD Device

N/A

ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of O

Heart Diseases

N/A

Clinical Trials (1)

NCT05174442ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices

N/A

Occlutech PDA occluder

Patent Ductus Arteriosus

N/A

Clinical Trials (1)

NCT01479218Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus

N/A

transcatheter closure of secundum atrial septal defects in patients

Secundum Atrial Septal Defects

N/A

Clinical Trials (1)

NCT04488120Occlutech Septal Occluder (Figulla Flex II) Study

N/A

Occlutech® PDA Occluder

Patent Ductus Arteriosus

N/A

Clinical Trials (1)

NCT05264753Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects

N/A

Occlutech muscular ventricular septal defect

Muscular Ventricular Septal Defect

N/A

Clinical Trials (1)

NCT05329350Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases

N/A

Pulmonary Embolism and Right-to-Left Shunts

Pulmonary Embolism (PE)

N/A

Clinical Trials (1)

NCT07519876Pulmonary Embolism and Right-to-Left Shunts

N/A

Implantation of LAA closure device

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT02105584Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation

N/A

Occlutech PFO Occluder

Stroke

N/A

Clinical Trials (1)

NCT04029233The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO

N/A

Occlutech AFR Device

Pulmonary Hypertension

N/A

Clinical Trials (1)

NCT03022851The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension

N/A

Occlutech AFR device

Heart Failure Low Output

N/A

Clinical Trials (1)

NCT03030274The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients

N/A

Investigational PFO Closure Device

Stroke

N/A

Clinical Trials (1)

NCT05069558Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

N/A

Atrial Flow Regulator

Heart Failure With Preserved Ejection Fraction (HFpEF)

N/A

Clinical Trials (2)

NCT07532369Occlutech AFR Fontan Study

N/A

NCT05136820Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study

N/A

Occlutech Atrial Flow Regulator

Heart Failure

N/A

Clinical Trials (1)

NCT04405583The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients

N/A

Prasugrel 5mg

Migraine Disease

Phase 3

Clinical Trials (1)

NCT07629635Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy